Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials

BACKGROUND: Mesenchymal stromal cells (MSCs) are considered to have a modest benefit on left ventricular ejection fraction (LVEF) in patients with acute myocardial infarction (AMI). However, the optimal injection timing and dose needed to induce beneficial cardiac effects are unknown. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zi, Wang, Lingling, Su, Xuan, Pu, Jun, Jiang, Meng, He, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273801/
https://www.ncbi.nlm.nih.gov/pubmed/28129790
http://dx.doi.org/10.1186/s13287-016-0450-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273801/
https://www.ncbi.nlm.nih.gov/pubmed/28129790
http://dx.doi.org/10.1186/s13287-016-0450-9

Ejemplares similares